MyFinsight
Home
Blog
About
Gross proceeds from
private placement
$4,999,848
Net cash provided by
financing activities
$4,918,831
(1753.65%↑ Y/Y)
Canceled cashflow
$81,017
Net decrease in
cash, cash...
-$3,878,807
(-40.35%↓ Y/Y)
Canceled cashflow
$4,918,831
Maturities of marketable
securities
$2,257,000
(-79.92%↓ Y/Y)
Collaboration receivables
-$452,867
(-124.93%↓ Y/Y)
Stock-based compensation
$109,310
(-73.43%↓ Y/Y)
Tax and other
receivables
-$91,340
(-413.90%↓ Y/Y)
Change in fair value of
contingent consideration
$89,414
(-78.35%↓ Y/Y)
Prepaid expenses and
other current assets
-$79,942
(81.85%↑ Y/Y)
Change in accrued
interest on marketable...
$78,912
Reduction of operating
lease right-of-use...
$40,795
(-13.87%↓ Y/Y)
Depreciation and
amortization
$10,741
(187.12%↑ Y/Y)
Other assets
-$2,883
(-108.12%↓ Y/Y)
Issuance costs for
private placement
$71,701
Taxes paid related to
net share...
$9,316
Net cash (used in)
provided by investing...
-$6,889,137
(-306.45%↓ Y/Y)
Canceled cashflow
$2,257,000
Net cash used in
operating activities
-$1,891,935
(70.93%↑ Y/Y)
Effect of exchange rate
changes on cash, cash...
-$16,567
(-111.69%↓ Y/Y)
Canceled cashflow
$956,204
Purchases of marketable
securities
$9,122,681
(11.58%↑ Y/Y)
Purchases of property and
equipment
$23,456
(-27.14%↓ Y/Y)
Net loss
-$2,079,010
(52.16%↑ Y/Y)
Accounts payable
-$378,492
(-174.28%↓ Y/Y)
Prepaid collaboration
expenses
$236,111
Investment income and fair
value adjustments on...
$61,459
(78.58%↑ Y/Y)
Accrued expenses
-$44,360
(97.95%↑ Y/Y)
Operating lease
liabilities
-$40,660
(-4.83%↓ Y/Y)
Accretion of discount on
marketable securities
$8,027
Change in unrealized
gain on cash...
-$14
Net realized gain on
marketable securities
$5
Back
Back
Cash Flow
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)
source: myfinsight.com